These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9152289)

  • 21. Growth deficiency in polytransfused beta-thalassaemia patients is not growth hormone dependent.
    Cavallo L; Gurrado R; Gallo F; Zacchino C; De Mattia D; Tatò L
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):701-6. PubMed ID: 9274700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced human growth hormone (hGH) bioactivity without a defect of the GH-1 gene in three patients with rhGH responsive growth failure.
    Binder G; Benz MR; Elmlinger M; Pflaum CD; Strasburger CJ; Ranke MB
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):89-95. PubMed ID: 10468970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone deficiency after childhood bone marrow transplantation with total body irradiation: interaction with adiposity and age.
    Davis NL; Stewart CE; Moss AD; Woltersdorf WW; Hunt LP; Elson RA; Cornish JM; Stevens MC; Crowne EC
    Clin Endocrinol (Oxf); 2015 Oct; 83(4):508-17. PubMed ID: 25807881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum insulin-like growth factor-I, IGF binding protein-3 and IGFBP-3 protease activity after cranial irradiation.
    Tillmann V; Shalet SM; Price DA; Wales JK; Pennells L; Soden J; Gill MS; Whatmore AJ; Clayton PE
    Horm Res; 1998; 50(2):71-7. PubMed ID: 9701699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel application of IGF-I and IGFBP-3 generation tests in the diagnosis of growth hormone axis disturbances in children with beta-thalassaemia.
    Chrysis DC; Alexandrides TK; Koromantzou E; Georgopoulos N; Vassilakos P; Kiess W; Kratsch J; Beratis NG; Spiliotis BE
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):253-9. PubMed ID: 11207641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of IGF-I, IGFBP-3, and IGFBP-2 measurements during GH treatment of GH-deficient and non-GH-deficient children and adolescents.
    Ranke MB; Schweizer R; Elmlinger MW; Weber K; Binder G; Schwarze CP; Wollmann HA
    Horm Res; 2001; 55(3):115-24. PubMed ID: 11549872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
    Thalange NK; Price DA; Gill MS; Whatmore AJ; Addison GM; Clayton PE
    Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study.
    Schmiegelow M; Lassen S; Poulsen HS; Feldt-Rasmussen U; Schmiegelow K; Hertz H; Müller J
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):191-7. PubMed ID: 10931100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGF-I and IGF-binding protein-3 measurements on filter paper blood spots in children and adolescents on GH treatment: use in monitoring and as markers of growth performance.
    Das U; Whatmore AJ; Khosravi J; Wales JK; Butler G; Kibirige MS; Diamandi A; Jones J; Patel L; Hall CM; Price DA; Clayton PE
    Eur J Endocrinol; 2003 Sep; 149(3):179-85. PubMed ID: 12943519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of free insulin-like growth factor-I measurement on the diagnosis and follow-up treatment of growth hormone-deficient adult patients.
    Musolino NR; Da Cunha Neto MB; Marino Júnior R; Giannella-Neto D; Bronstein MD
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):441-9. PubMed ID: 10468902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Low sensitivity of IGF-I, IGFBP-3 and urinary GH in the diagnosis of growth hormone insufficiency in slowly-growing short-statured boys. Grupo Español de Estudio de la Talla Baja].
    Audí L; Antonia Llopis M; Luisa Granada M; Hermoso F; del Valle J; Dolores Rodríguez-Arnao M; Bel J; Luzuriaga C; Gallego E; Marín F;
    Med Clin (Barc); 2001 Jan; 116(1):6-11. PubMed ID: 11181253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reevaluation of growth hormone deficiency during and after growth hormone (GH) treatment: diagnostic value of GH tests and IGF-I and IGFBP-3 measurements.
    Darendeliler F; Spinu I; Bas F; Bundak R; Isgüven P; Arslanoğlu I; Saka N; Sükür M; Günöz H
    J Pediatr Endocrinol Metab; 2004 Jul; 17(7):1007-12. PubMed ID: 15301049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation.
    Papadimitriou A; Urena M; Hamill G; Stanhope R; Leiper AD
    Arch Dis Child; 1991 Jun; 66(6):689-92. PubMed ID: 2053788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A; Skakkebaek NE
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
    Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
    Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term increments of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 predict the growth response to growth hormone (GH) therapy in GH-sensitive children.
    Schwarze CP; Wollmann HA; Binder G; Ranke MB
    Acta Paediatr Suppl; 1999 Feb; 88(428):200-8. PubMed ID: 10102080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.